UnitedHealth Group Incorporated (NYSE:UNH) is IFM Investors Pty Ltd’s 9th Largest Position

IFM Investors Pty Ltd boosted its holdings in shares of UnitedHealth Group Incorporated (NYSE:UNHGet Rating) by 20.1% in the first quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm owned 149,484 shares of the healthcare conglomerate’s stock after acquiring an additional 25,063 shares during the quarter. UnitedHealth Group accounts for 1.2% of IFM Investors Pty Ltd’s portfolio, making the stock its 9th biggest holding. IFM Investors Pty Ltd’s holdings in UnitedHealth Group were worth $76,232,000 as of its most recent SEC filing.

A number of other large investors also recently bought and sold shares of UNH. Outfitter Financial LLC bought a new stake in UnitedHealth Group during the 4th quarter valued at $25,000. Advocacy Wealth Management Services LLC raised its position in shares of UnitedHealth Group by 75.8% in the 1st quarter. Advocacy Wealth Management Services LLC now owns 58 shares of the healthcare conglomerate’s stock worth $30,000 after acquiring an additional 25 shares in the last quarter. Cascade Investment Advisors Inc. raised its position in shares of UnitedHealth Group by 100.0% in the 1st quarter. Cascade Investment Advisors Inc. now owns 60 shares of the healthcare conglomerate’s stock worth $31,000 after acquiring an additional 30 shares in the last quarter. Tortoise Investment Management LLC raised its position in shares of UnitedHealth Group by 54.8% in the 4th quarter. Tortoise Investment Management LLC now owns 65 shares of the healthcare conglomerate’s stock worth $33,000 after acquiring an additional 23 shares in the last quarter. Finally, Leverty Financial Group LLC bought a new position in shares of UnitedHealth Group in the 4th quarter worth $34,000. Hedge funds and other institutional investors own 87.48% of the company’s stock.

Wall Street Analysts Forecast Growth

Several research firms have recently commented on UNH. Truist Financial boosted their price target on UnitedHealth Group from $575.00 to $610.00 in a research report on Thursday, April 7th. Morgan Stanley boosted their target price on UnitedHealth Group from $570.00 to $587.00 in a research note on Monday, July 18th. Cowen boosted their target price on UnitedHealth Group from $512.00 to $596.00 in a research note on Monday, April 18th. Cowen boosted their target price on UnitedHealth Group from $512.00 to $596.00 in a research note on Monday, April 18th. Finally, Argus boosted their target price on UnitedHealth Group from $580.00 to $650.00 and gave the stock a “buy” rating in a research note on Monday, July 25th. Three investment analysts have rated the stock with a hold rating, sixteen have given a buy rating and two have given a strong buy rating to the company’s stock. According to data from MarketBeat, UnitedHealth Group has an average rating of “Moderate Buy” and an average target price of $582.50.

Insider Buying and Selling at UnitedHealth Group

In other UnitedHealth Group news, Director Richard T. Burke sold 2,500 shares of the stock in a transaction that occurred on Thursday, May 19th. The stock was sold at an average price of $478.96, for a total transaction of $1,197,400.00. Following the completion of the transaction, the director now owns 1,215,000 shares of the company’s stock, valued at $581,936,400. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this hyperlink. In other news, Director Richard T. Burke sold 2,500 shares of the company’s stock in a transaction that occurred on Thursday, May 19th. The stock was sold at an average price of $478.96, for a total value of $1,197,400.00. Following the completion of the sale, the director now directly owns 1,215,000 shares in the company, valued at $581,936,400. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. Also, CFO John F. Rex sold 13,183 shares of the company’s stock in a transaction that occurred on Friday, July 29th. The shares were sold at an average price of $541.53, for a total value of $7,138,989.99. Following the completion of the sale, the chief financial officer now owns 141,508 shares of the company’s stock, valued at $76,630,827.24. The disclosure for this sale can be found here. Insiders sold 130,144 shares of company stock valued at $69,269,555 over the last quarter. 0.40% of the stock is currently owned by insiders.

UnitedHealth Group Stock Performance

NYSE UNH opened at $542.34 on Monday. The stock has a market capitalization of $508.81 billion, a price-to-earnings ratio of 28.32, a PEG ratio of 1.64 and a beta of 0.77. UnitedHealth Group Incorporated has a twelve month low of $383.12 and a twelve month high of $553.29. The company has a current ratio of 0.77, a quick ratio of 0.78 and a debt-to-equity ratio of 0.60. The stock has a 50-day moving average of $502.80 and a 200 day moving average of $497.45.

UnitedHealth Group (NYSE:UNHGet Rating) last released its quarterly earnings results on Friday, July 15th. The healthcare conglomerate reported $5.57 earnings per share for the quarter, topping analysts’ consensus estimates of $5.24 by $0.33. The company had revenue of $80.33 billion during the quarter, compared to analysts’ expectations of $79.68 billion. UnitedHealth Group had a return on equity of 25.45% and a net margin of 5.95%. UnitedHealth Group’s quarterly revenue was up 12.6% compared to the same quarter last year. During the same quarter in the prior year, the firm posted $4.70 EPS. Sell-side analysts anticipate that UnitedHealth Group Incorporated will post 21.84 EPS for the current fiscal year.

UnitedHealth Group Increases Dividend

The company also recently announced a quarterly dividend, which was paid on Tuesday, June 28th. Shareholders of record on Monday, June 20th were issued a dividend of $1.65 per share. The ex-dividend date was Thursday, June 16th. This represents a $6.60 dividend on an annualized basis and a dividend yield of 1.22%. This is a boost from UnitedHealth Group’s previous quarterly dividend of $1.45. UnitedHealth Group’s dividend payout ratio is presently 34.46%.

UnitedHealth Group Profile

(Get Rating)

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. It operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage and well-being services to individuals age 50 and older addressing their needs for preventive and acute health care services, as well as services dealing with chronic disease and other specialized issues for older individuals; Medicaid plans, children's health insurance and health care programs; health and dental benefits; and hospital and clinical services.

Featured Stories

Institutional Ownership by Quarter for UnitedHealth Group (NYSE:UNH)

Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.